Global Neuromodulation Devices Market is Expected to Reach USD 7,072.6 Million in 2018: Transparency Market Research

Informations

• Publié par: transparency-market-research
• Nombre de lectures: 8
• Langue: English

Extrait

Global Neuromodulation Devices Market is Expected to Reach USD 7,072.6 Million in 2018: Transparency Market Research

PR Newswire ALBANY, New York, October 30, 2012

ALBANY, New York,October 30, 2012/PRNewswire/ --

According to a new market report published by Transparency Market Research (http://www.transparencymarketresearch.com)"Neuromodulation Devices Market - Global Industry Analysis, Size, Share and Forecast, 2012-2018,"the global neuromodulation devices market was valued atUSD 2,758 millionin 2011 and is expected to grow at a CAGR of 14.4% from 2012 to 2018, to reach an estimated value ofUSD 7,072.6 millionby 2018.

Browse the full report athttp://www.transparencymarketresearch.com/global-neuromodulation-devices- market.html

The market is driven by factors such as the aging w orld population leading to chronic diseases such as Parkinson's and Alzheimer's disorders and technological advancements in the field of neuromodulation devices including the invention of transdermal neuromodulation technology by NMT (Neurowave Medical Technologies). Moreover, the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, the availability of external funding to conduct clinical studies to help come up with new and technologically advanced products and the rising healthcare related consumer expenditure have also driven the growth in this market. The fact that a neuromodulation device could be used as an add-on treatment and so can be used simultaneously with other medications also drives the market forward.

The North American region holds majority of the market share and accounted for a share of 65% in 2011. The North Americanneuromodulation device marketwas valued atUSD 1,792.7 millionin 2011. The economic developments in the Asia Pacific region make it the fastest growing region (CAGR of more than 15% from 2012 to 2018) in the neuromodulation devices market.

The future growth of the market will be ensured by capitalizing on market opportunities such as increasing healthcare related consumer expenditure in emerging economies in the Asia Pacific, Latin American and Eastern European regions. The availability of medical device manufacturing outsourcing options helps in curbing costs and thereby enhances profit margins. Also, the presence of consolidation options in the healthcare industry helps in strengthening the revenue base to conduct R&D exercises for new product development and thus helps in strengthening market share.

Related Reports:

http://www.transparencymarketresearch.com/preimplantation-genetic-diagnosis-market.html

http://www.transparencymarketresearch.com/cervical-cancer-diagnostic-tests-market.html

http://www.transparencymarketresearch.com/home-healthcare-market.html

http://www.transparencymarketresearch.com/us-vaccine-market.html

Implementation of the Affordable Healthcare for America Act, 2010 which imposes an excise tax of 2.5% on medical devices and the stringent FDA regulations are some of the factors restraining the growth of the market. Risks involved in using a neuromodulation device such as injury to the vagus nerve and nearby blood vessels (carotid artery and jugular vein) in case of a vagus nerve pacemaker also impedes the growth of the market.

Neuromodulation Devices Market by Technology

Spinal Cord Stimulation Devices Deep Brain Stimulation Devices Vagus Nerve Stimulation Devices Sacral Nerve Stimulation Devices Gastric Electric Stimulation Devices

Neuromodulation Systems for Different Application A reas

Medtronic's Spinal Cord and Deep Brain Neurostimulation Systems St. Jude Medical's Eon Mini Neurostimulator System Boston Scientific's Precision Spinal Cord Stimulation System Nevro's Senza System for Spinal Cord Stimulation Cyberonics' VNS Therapy System Codman & Shurtleff's Medstream system

Medtronic's Enterra™ Therapy System IntraPace's abiliti system

Neuromodulation Devices Market by Geography

North America Europe Asia Pacific RoW (Rest of the World)

Browse allPharmaceuticalMarketResearch Reports

Upcoming Reports inPharmaceuticalMarket

Membrane Bioreactor (MBR) Market

Smart Pill Technology Market

Bioinformatics Market

Hormone Replacement Therapy Market

Agricultural Biotechnology Market

Acute Myeloid Leukemia (AML) Therapeutics Market

Freeze Drying Equipment Market

Antibiotic Market

Bio-Implants Market

pH Meters Market

About Us

Transparency Market Research is a global market intelligence company, providing global business inform ation reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Sheela AK 90 Sate Street, Suite 700 Albany, NY 12207 Tel: [phone] USA - Canada Toll Free: 866-552-3453 Email:[e-mail] Podcast:http://transparencymarketresearch.podbean.com/